<html><head><meta http-equiv="content-type" content="text/html; charset=utf-8"></head><body dir="auto"><div>The DEA website has easy to understand materials for you. <br><br>Sent from Jim Hunter's iPhone</div><div><br>On Oct 13, 2014, at 8:43 AM, Gilliam, Allen <<a href="mailto:GILLIAM@adeq.state.ar.us">GILLIAM@adeq.state.ar.us</a>> wrote:<br><br></div><blockquote type="cite"><div><meta http-equiv="Content-Type" content="text/html; charset=us-ascii"><meta name="Generator" content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-reply;
font-family:"Arial","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--><div class="WordSection1"><p class="MsoNormal"><span style="font-family:"Arial","sans-serif";color:#1F497D">Ok, I have to admit I haven’t read the new DEA reg very carefully. How would it affect current take-back programs with LE? Is it the controlled substance requirements? Please break this down in the simplest terms possible ‘cause this really isn’t in my job description.<o:p></o:p></span></p><p class="MsoNormal"><span style="font-family:"Arial","sans-serif";color:#1F497D"><o:p> </o:p></span></p><p class="MsoNormal"><span style="font-family:"Arial","sans-serif";color:#1F497D">Allen Gilliam<o:p></o:p></span></p><p class="MsoNormal"><span style="font-family:"Arial","sans-serif";color:#1F497D">ADEQ State Pretreatment Coordinator<o:p></o:p></span></p><p class="MsoNormal"><span style="font-family:"Arial","sans-serif";color:#1F497D">501.682.0625<o:p></o:p></span></p><p class="MsoNormal"><span style="font-family:"Arial","sans-serif";color:#1F497D"><o:p> </o:p></span></p><div><div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in"><p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> <a href="mailto:pharmwaste-bounces@lists.dep.state.fl.us">pharmwaste-bounces@lists.dep.state.fl.us</a> [<a href="mailto:pharmwaste-bounces@lists.dep.state.fl.us">mailto:pharmwaste-bounces@lists.dep.state.fl.us</a>] <b>On Behalf Of </b>Jaramillo, Jeanie<br><b>Sent:</b> Friday, October 10, 2014 3:39 PM<br><b>To:</b> <a href="mailto:pharmwaste@lists.dep.state.fl.us">pharmwaste@lists.dep.state.fl.us</a><br><b>Subject:</b> [Pharmwaste] Group discussion on take back programs<o:p></o:p></span></p></div></div><p class="MsoNormal"><o:p> </o:p></p><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black">To those who have been conducting take back programs with law enforcement, <o:p></o:p></span></p><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p> </o:p></span></p></div><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black">Now that the new DEA rule has been out for a bit and we've had some time to absorb the information, I am interested in coordinating a group discussion for those who have been conducting take back programs with law enforcement and are now concerned that they may have to discontinue their programs. <o:p></o:p></span></p></div><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p> </o:p></span></p></div><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black">If you're interested in having a discussion, perhaps sometime next week, please email me directly at <a href="mailto:jeanie.jaramillo@ttuhsc.edu">jeanie.jaramillo@ttuhsc.edu</a> . <o:p></o:p></span></p><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p> </o:p></span></p><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">Jeanie Jaramillo, PharmD</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"> <o:p></o:p></span></p><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">Managing Director, Texas Panhandle Poison Center</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p></o:p></span></p></div><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">Asst. Professor, Texas Tech UHSC School of Pharmacy</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p></o:p></span></p></div><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">1300 S. Coulter St., Suite 105</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p></o:p></span></p></div><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">Amarillo, TX 79106</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p></o:p></span></p></div><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">(office): (806)414-9299</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p></o:p></span></p></div><div><p class="MsoNormal"><i><span style="font-size:10.0pt;font-family:"Verdana","sans-serif";color:black">(mobile): (806)376-0039</span></i><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p></o:p></span></p><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black"><o:p> </o:p></span></p></div></div></div></div></div></div></div></div></blockquote><blockquote type="cite"><div><span>---</span><br><span>Note: As a courtesy to other listserv subscribers, please post messages to the listserv in plain text format to avoid the garbling of messages received by digest recipients.</span><br><span>---</span><br><span>TO SUBSCRIBE, go to: <a href="http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste">http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste</a> </span><br><span>TO UNSUBSCRIBE, DO NOT REPLY TO THE LISTSERV. Please send an e-mail to <a href="mailto:pharmwaste-unsubscribe@lists.dep.state.fl.us">pharmwaste-unsubscribe@lists.dep.state.fl.us</a> -- the subject line and body of the e-mail should be blank.</span><br><span>If you believe you may be subscribed with a different email address, please visit the subscriber listing at <a href="http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste">http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste</a> </span><br><span>FOR PROBLEMS: Contact List Administrator <a href="mailto:Laurie.Tenace@dep.state.fl.us">Laurie.Tenace@dep.state.fl.us</a> </span><br><span>SEND MAIL to the list server at: <a href="mailto:pharmwaste@lists.dep.state.fl.us">pharmwaste@lists.dep.state.fl.us</a></span><br></div></blockquote></body></html>